Whittier Trust’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Whittier Trust’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4	Closed	-$1.27K	–	1577
2023 Q4	$1.27K	Buy	+4	New	+$778	﹤0.01%	1433

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Whittier Trust's KRTX Position: Q1 2024 in Review

Whittier Trust sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 4 shares — an estimated $1.27K sold.

Whittier Trust first reported a position in KRTX in Q4 2023 and held it in 1 quarter. The position peaked at $1.27K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Whittier Trust reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Whittier Trust sold 4 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.27K.
Whittier Trust first reported a position in Karuna Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Whittier Trust's Karuna Therapeutics, Inc. Common Stock position peaked at $1.27K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Whittier Trust's 13F filing for Q1 2024, filed 2 May 2024.